This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available:
Introduction
Mammary analogue secretory carcinoma (MASC) is a rare tumour of the salivary glands that was first described by Skálová et al in 2010. 1 It usually presents with microcystic architecture and low-grade cytological features, and is histomorphologically and immunohistochemically similar to secretory carcinoma of the breast. The histological features can resemble other salivary tumours such as cystadenocarcinoma and acinic cell carcinoma. Its most commonly described site is the major salivary glands, but there are only a handful of reported cases of it affecting the minor salivary glands of the lip.
We report two cases of MASC of the upper lip, which showed locally aggressive biological behaviour and required a more aggressive treatment than that adopted for histological mimics such as acinic cell carcinoma.
Case 1
An otherwise healthy 27-year-old woman presented with a one-year history of a slowgrowing 1.5 cm lump, on her right upper lip. Cytological analysis of ultrasound-guided fine needle aspirate suggested a salivary gland neoplasm that raised the possibility of acinic cell carcinoma. The lesion was excised and histopathological analysis confirmed the diagnosis of MASC after immunohistochemical studies had stained for S100 and mammaglobin. It did not stain for DOG1. Fluorescent in situ hybridisation confirmed rearrangement of the ETV6 gene.
Staging scans showed no evidence of metastases. The margins of the specimen were invaded on histopathological analysis despite the impression of macroscopic clearance at operation. She subsequently had a wedge excision of the scar with a 1cm margin but then required a repeat resection after microscopic identification of residual dispersed islands of tumour that had reached the margins. The patient had no signs of local or regional recurrence nine months after her operation (Figs. 1-3).
Case 2
A 51-year-old man who used to smoke and had no other relevant medical history presented with a three-year history of an asymptomatic, firm, mobile lump in his upper right labial mucosa. Histopathological examination of an excisional biopsy specimen together with immunohistochemical profile and fluorescent in situ hybridisation again suggested a diagnosis of MASC. Staging scans showed no abnormality.
The patient had a further excision of the scar with a 1cm margin under general anaesthetic.
Final histopathological analysis again showed residual tumour with a close margin at the deeper aspect of the specimen. The patient declined any further intervention so a policy of close follow-up was adopted. There were no signs of local or regional recurrence at his sixmonth review.
Discussion
Because MASC was not recognised as a distinct entity until 2010 it is not listed in the most recent 2005 WHO classification of salivary gland tumours. 3 We know of about 90 cases of MASC that have been published -two thirds of which were in the parotid gland, followed by the intraoral minor salivary glands and the submandibular gland. 4 MASC resembles secretory carcinoma of the breast and expresses the same ETV6-NTRK3 gene fusion protein, which leads to constitutive activation of two major effector pathwaysthe Ras-MAP kinase mitogenic pathway and the phosphatidyl inositol-3-kinase-AKT pathway. 5 This translocation has not been found in conventional salivary acinic cell carcinoma. There are, however, differences in immunohistochemical profile: MASC reacts to mammaglobin and S100 while acinic cell carcinoma shows no appreciable expression of these markers. 1 The morphology of these two tumours can be similar, which can lead to errors of interpretation. 1, 6, 7 Both of these case studies involved minor salivary glands of the upper lip and we managed them the same way we would an acinic cell carcinoma. Previous publications have suggested that the management of MASC should be similar, but its histological behavior is more aggressive and it is difficult to obtain microscopically clear margins despite the impression of adequate macroscopic clearance. 8 We advise a more aggressive approach to the treatment of MASC tumours that affect the minor salivary glands.
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